A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-Release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.
This study has been completed.
Study NCT00269750.
Last updated on April 6, 2007.
Information provided by Alza Corporation, DE, USA
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
